放射外科术前磁共振成像上脑转移瘤的生长
该研究回顾2010至2013年在本机构接受固定框架立体定向放射外科(SRS)治疗脑转移瘤的患者,比较治疗前诊断性MRI与SRS计划MRI上的肿瘤体积,量化SRS前脑转移瘤的生长。结果显示两次MRI间隔时间与转移瘤生长相关(P < .001),平均生长速率0.02 ml/天(95%CI 0.01-0.03),14天时体积增加1.35倍;在固定框架SRS患者中,局部控制(LC)与生长速率无关。
要点
- 两次MRI间隔时间与脑转移瘤生长相关(P < .001),平均生长速率0.02 ml/天(95%CI 0.01-0.03)。
- 14天时脑转移瘤体积增加1.35倍。
- 固定框架SRS患者中局部控制与生长速率无关。
核心结论
- 治疗前MRI与SRS之间的时间间隔与脑转移瘤生长相关,但接受固定框架SRS并同日MRI计划的患者局部控制未受影响。
- 对于接受无框架SRS的转移瘤,可能需要外扩边界以弥补计划MRI与SRS实施之间的生长。
研究设计与样本
- 回顾性分析2010至2013年在本机构接受固定框架SRS治疗脑转移瘤、且具备治疗前诊断性脑MRI和SRS计划MRI扫描的患者数据。
- 在治疗前MRI和当日治疗计划MRI上勾画转移瘤并进行体积比较,计算生长速率。
- 利用治疗前MRI上的连续体积轮廓外扩确定在SRS当日覆盖整个转移瘤所需的最小边界。
- 采用Kaplan-Meier法估计局部控制。
主要发现
- 共纳入165例患者的411个脑转移瘤。
- 治疗前与治疗MRI之间的时间与转移瘤生长相关(P < .001),平均生长速率0.02 ml/天(95%CI 0.01-0.03),14天时体积增加1.35倍。
- MRI扫描间隔时间与SRS当日覆盖整个脑转移瘤体积所需边界量相关(P < .001)。
- 治疗前MRI上的转移瘤体积(P < .001)和黑色素瘤组织学(P < .001)也与所需边界量相关。
- 在固定框架SRS患者中,局部控制与生长速率无关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: A previous analysis showed that brain metastases that are treated with frameless stereotactic radiation surgery (SRS) and planned with magnetic resonance imaging (MRI) >14 days before SRS had worse local control (LC). To evaluate if worse LC may be due to unaccounted interval metastasis growth and radiosurgical marginal miss, we quantified growth before SRS on preradiosurgical imaging. METHODS AND MATERIALS: We reviewed data from patients who were treated with fixed-frame SRS for brain metastases at our institution between 2010 and 2013 and had pretreatment diagnostic brain MRI and SRS-planning MRI scans available. Metastases were contoured on the pretreatment MRI scan and the day-of-treatment planning MRI scan for volumetric comparison. Growth rates were calculated. Serial volumetric contour expansions on the pretreatment MRI scans were used to determine the minimum margin necessary to encompass the entire metastasis on day of the SRS. LC was estimated by Kaplan-Meier method. RESULTS: Among 411 brain metastases in 165 patients, the time between pretreatment and treatment MRI was associated with metastasis growth (P < .001) with a mean growth rate of 0.02 ml/day (95% confidence interval, 0.01-0.03) and a 1.35-fold volume increase at 14 days. Time between MRI scans was associated with the amount of margin that was needed to target the entire brain metastasis volume on the day of the SRS (P < .001), as were volume of metastasis on the pre-treatment MRI (P < .001) and melanoma histology (P < .001). LC was not associated with growth rate among patients who underwent fixed-frame SRS. CONCLUSIONS: Time between pretreatment MRI and SRS is associated with brain metastasis growth, but LC is not compromised when patients receive fixed-frame SRS with same-day MRI planning. Margins may be needed for metastases that are treated with frameless SRS to account for growth between the planning MRI and SRS delivery. SUMMARY: In this study, we quantify brain metastasis growth over time by taking advantage of the availability of 2 pretreatment magnetic resonance imaging scans taken at 2 time points among patients treated with frame-fixed radiation surgery. We found that metastasis growth is associated with time, initial metastasis size, melanoma histology, and concurrent chemotherapy. Performing serial margin expansions demonstrated factors that are associated with the amount of margin that is needed to target the entire metastasis on the day of radiation surgery.
引用
- Garcia MA, Anwar M, Yu Y, et al. Brain metastasis growth on preradiosurgical magnetic resonance imaging. Pract Radiat Oncol. 2018. PMID: 30174247. doi:10.1016/j.prro.2018.06.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。